| Total sampled | Humans only | Humans and pets | Pets only |
---|---|---|---|---|
Baseline study visit | Â | Â | Â | Â |
 Households |  |  |  |  |
 Number of households | 25 | 3 | 4 | 18 |
 Number of people, median (range) | 4 (1–8) | 4 (2–5) | 5 (4–7) | 4 (1–8) |
 Number of pets, median (range) | 2 (0–13) | 0 | 2 (1–10) | 2 (1–13) |
 Human subjects |  |  |  |  |
Index subjects | 6 | 3 | 3 | - |
  Female:male | 3:3 | 2:1 | 1:2 | - |
  Age in years, median (range) | 8.5 (2–48) | 5 (2–48) | 13 (6–15) | - |
  CPS + at any site, n = 4 | 3 | 1 | 2 |  |
  S. aureus + at any site, n = 4 | 1 | 1 | 0 |  |
  MRSA + at any site | 1 | 1 | 0 | - |
 Non-index subjects | 24 | 7 | 17 | - |
  Female:male | 12:12 | 4:3 | 8:9 | - |
  Age in years, median (range) | 25 (3–54) | 23 (9–42) | 26 (3–54) | - |
  CPS + at any site, n = 18 | 15 | 1 | 14 |  |
  S. aureus + at any site, n = 18 | 3 | 0 | 3 |  |
  MRSA + at any site | 3 | 0 | 3 | - |
 Pet subjects |  |  |  |  |
 Dogs | 36 | - | 5 | 31 |
  Female:male | 21:15 | - | 3:2 | 18:13 |
  Age in months, median (range) | 24 (2–132) | - | 24 (6–120) | 24 (2–132) |
  Neutered:unneutered | 9:27 | - | 1:4 | 8:23 |
  CPS + at any site | 34 | - | 4 | 30 |
  S. aureus + at any site | 6 | - | 1 | 5 |
  MRSA + at any site | 2 | - | 2 | 0 |
 Cats | 20 | - | 3 | 17 |
  Female:male | 11:9 | - | 3:0 | 8:9 |
  Age in months, median (range) | 27 (4–135) | - | 12 (8–20) | 53 (4–135) |
  Neutered:unneutered | 16:4 | - | 2:1 | 14:3 |
  CPS + at any site | 13 | - | 2 | 11 |
  S. aureus + at any site | 4 | - | 1 | 3 |
  MRSA + at any site | 2 | - | 2 | 0 |
Three-month follow-up study visit | Â | Â | Â | Â |
 Households |  |  |  |  |
 Number of households | 20 | 2 | 3 | 15 |
 Number randomized to treatment | 12 | 2 | 2 | 8 |
 Number of people, median (range) | 4 (1–8) | 4.5 (4–5) | 5 (4–7) | 4 (1–8) |
 Number of pets, median (range) | 2 (0–10) | 0 | 2 (1–8) | 3 (1–10) |
 Human subjects |  |  |  |  |
 Index subjects | 4 | 2 | 2 | - |
 Randomized to treatment | 3 | 2 | 1 | - |
 Female:male | 1:3 | 1:1 | 0:2 | - |
 Age in years, median (range) | 9 (2–15) | 3.5 (2–5) | 14 (13–15) | - |
 CPS + at any site, n = 4 | 3 | 0 | 3 |  |
  S. aureus + at any site, n = 4 | 1 | 0 | 1 |  |
 MRSA + at any site | 0 | 0 | 0 | - |
 Non-index subjects | 17 | 6 | 11 | - |
  Randomized to treatment | 14 | 6 | 8 |  |
  Female:male | 8:9 | 3:3 | 5:6 | - |
  Age in years, median (range) | 26 (3–54) | 21 (9–42) | 26 (3–54) | - |
  CPS + at any site, n = 14 | 11 | 3 | 8 |  |
  S. aureus + at any site, n = 14 | 4 | 1 | 3 |  |
  MRSA + at any site | 0 | 0 | 0 | - |
 Pet subjects |  |  |  |  |
 Dogs | 19 | - | 4 | 15 |
  Female:male | 12:7 | - | 2:2 | 10:5 |
  Age in months, median (range) | 37 (6–132) | - | 42 (6–120) | 37 (9–132) |
  Neutered:unneutered | 7:12 | - | 1:3 | 6:9 |
  CPS + at any site | 17 | - | 3 | 14 |
  S. aureus + at any site | 4 |  | 0 | 4 |
  MRSA + at any site | 3 | - | 0 | 3 |
 Cats | 14 | - | 2 | 12 |
  Female:male | 8:6 | - | 2:0 | 6:6 |
  Age in months, median (range) | 15 (4–135) | - | 10 (8–12) | 23 (4–135) |
  Neutered:unneutered | 10:4 | - | 1:1 | 9:3 |
  CPS + at any site | 11 | - | 1 | 10 |
  S. aureus + at any site | 4 |  | 0 | 4 |
  MRSA + at any site | 1 | - | 0 | 1 |